Improving treatment for bladder cancer through genetic profiling and immunotherapy
SPORE in Bladder Cancer
This study is looking at how changes in the genes of bladder cancer tumors and blood can help doctors create better, personalized treatment plans for patients, including the use of immunotherapy, to improve their chances of responding well to different treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11196451 on NIH RePORTER |
What this research studies
This research focuses on bladder cancer, aiming to enhance treatment outcomes by analyzing genetic changes in tumors and blood samples. By understanding how these genetic alterations affect drug sensitivity, the study seeks to personalize treatment plans for patients. The project also explores the use of immunotherapy and aims to identify biomarkers that predict responses to various treatments. A multidisciplinary team is involved to ensure comprehensive care and innovative approaches to combat bladder cancer.
Who could benefit from this research
Good fit: Ideal candidates include individuals diagnosed with bladder cancer who are seeking advanced treatment options.
Not a fit: Patients with non-cancerous bladder conditions or those who are not diagnosed with bladder cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective, personalized treatment options for bladder cancer patients.
How similar studies have performed: Previous research has shown promising results in using genetic profiling and immunotherapy for other cancers, indicating potential success for this approach in bladder cancer as well.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Rosenberg, Jonathan Eric — Sloan-Kettering Inst Can Research
- Study coordinator: Rosenberg, Jonathan Eric
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.